111
Views
46
CrossRef citations to date
0
Altmetric
Original Article

The Enzymology of Skeletal Muscle Disorders

&
Pages 153-190 | Published online: 02 Jul 2009

References

  • Rosalki S. B. Enzymes in diseases of skeletal muscle. The Principles and Practice of Diagnostic Enzymology, J. H. Wilkinson. Year Book Medical Publishing, Chicago 1976; 261
  • Robbins S. L. Pathologic Basis of Disease. W. B. Saunders, Philadelphia 1974; 1420
  • Tyler F. H. Metabolic Basis of Inherited Diseases. 3rd ed., J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson. McGraw-Hill, New York 1972; 1204
  • Gardner-Medwin D. Clinical features and classification of the muscular dystrophies. Br. Med. Bull. 1980; 36: 109
  • Emery A. E. H. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br. Med. Bull. 1980; 36: 117
  • Roses A. D., Roses M. J., Nicholson G. A., et al. Lactate dehydrogenase isoenzyme 5 in detecting carriers of Duchenne muscular dystrophy. Neurology 1977; 27: 414
  • Burt D., Emery A. F. H. Serum LDH-5 in carriers of Duchenne muscular dystrophy. Neurology 1979; 29: 239
  • Somer H., Willner J., deCresce R. P., et al. Duchenne carriers: lactate dehydrogenase isoenzyme 5 in serum and muscle. Neurology 1980; 30: 206
  • Lindenbaum R. H., Clarke G., Patel C., et al. Muscular dystrophy in an X; 1 translocation female suggests that Duchenne locus is on X chromosome short arm. J. Med. Genet. 1979; 16: 389
  • Tzvetanova E. Serum creatine kinase isoenzymes in progressive muscular dystrophy. Enzyme 1978; 23: 238
  • Takahashi K., Shutta K., Matsuo B., et al. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy. Clin. Chem. Acta 1977; 75: 422
  • Lott J. A., Stang J. M. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin. Chem. 1980; 26: 1241
  • Silverman L. M., Mendell J. R., Sahenk Z., et al. Significance of creatine kinase isoenzymes in Duchenne dystrophy. Neurology 1976; 26: 561
  • Perloff J. Cardiomyopathy associated with heredofamilial neuropathic diseases. Mod. Concepts Cardiovasc. Dis. 1971; 40: 23
  • Somer H., Dubowitz V., Donner M. Creatine kinase isoenzymes in neuromuscular diseases. J. Neurol. Sci. 1976; 29: 129
  • Jockers-Wretou E., Grabert K., Mueller E., et al. Serum creatine kinase isoenzyme pattern in nervous system atrophies and neuromuscular disorders. Clin. Chim. Acta. 1976; 73: 183
  • Goedde H. W., Benkmann H. G., Das P. K., et al. Activity of creatine kinase isoenzyme MB in serum and red cell acetylcholinesterase variants in patients with Duchenne muscular dystrophy. Klin. Wschr. 1977; 55: 215
  • Goedde H. W., Christ I., Benkmann H. G., et al. Creatine kinase isoenzyme patterns in Duchenne muscular dystrophy. Clin. Genet. 1978; 14: 257
  • Diskin C. J. Creatine phosphokinase MB band in oculopharyngeal muscular dystrophy. New Engl. J. Med. 1979; 301: 270
  • Calandi C., Guidotti T., Tozzi P., et al. Valutazione della Piruvatochinasi Sierica nei Pazienti affetti da Distrofia Muscolare di Duchenne e nelle Portatrici. Min. Ped. 1981; 33: 453
  • Kuby S. A., Keutel H. J., Okabe K., et al. Isolation of human ATP-creatine transphosphorylases (creatine phosphokinases) from tissues of patients with Duchenne muscular dystrophy. J. Biol. Chem. 1977; 252: 8382
  • Yasmineh W. G., Ibrahim G. A., Abbasnezhad M., et al. Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin. Chem. 1978; 24: 1985
  • Munsat T. Creatine phosphokinase alterations in neuromuscular diseases. Isr. J. Med. Sci. 1977; 13: 93
  • Weinstock I. M., Behrendt J., Wiltshire H. E., et al. Pyruvate kinase: diagnostic value in neuromuscular disease. Clin. Chim. Acta 1977; 80: 415
  • Zatz M., Shapiro L. J., Campion D. S., et al. Serum pyruvate kinase (PK.) and creatine phosphokinase (CPK) in progressive muscular dystrophies. J. Neurol. Sci. 1978; 36: 349
  • Seay A. R., Ziter F. A., Wu L. H., et al. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers. Neurology 1978; 28: 1047
  • Kiessling W. R., Beckmann R. Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy. Klin. Wschr. 1981; 59: 347
  • Demos J. T., Tuil D. G., Katz P. C., et al. Diphenoloxidases in X-linked recessive (Duchenne) muscular dystrophy. Hum. Genet. 1981; 59: 154
  • Heath R., Jeffery S., Carter N. Radioimmunoassay of human muscle carbonic anhydrase III in dystrophic states. Clin. Chim. Acta 1982; 119: 299
  • Burri B. J., Chan S. G., Berry A. J., et al. Blood levels of superoxide dismutase and glutathione peroxidase in Duchenne muscular dystrophy. Clin. Chim. Acta 1980; 105: 249
  • Hunter M. I. S., Brzeski M. S., de Vane P. J. Superoxide dismutase, glutathione peroxidase and thiobarbituric acid-reactive compounds in erythrocytes in Duchenne musular dystrophy. Clin. Chim. Acta 1981; 115: 93
  • Sen S., Das P. K. Steroid-induced CPK estimation—a new diagnostic test for human muscular dystrophy and its carrier state. Arch. Dis. Child. 1978; 53: 521
  • Mawatari S., Antoku Y., Kuroiwa Y. Erythrocyte, membrane cation-stimulated ATPase activities in myotonic muscular dystrophy. J. Neurol. Sci. 1982; 53: 23
  • Ruitenbeek W., Scholte H. R. (Ca++ + Mg++) ATPase of red cells in Duchenne and myotonic dystrophy. Neurology 1980; 30: 1132
  • Igisu H., Mawatari S., Kuroiwa Y., Miyoshino S. Erythrocyte acetylcholinesterase in Duchenne muscular dystrophy. Clin. Chim. Acta 1980; 105: 241
  • Igisu H., Antoku Y., Mawatari S., et al. Erythrocyte membrane in myotonic dystrophy. J. Neurol. Sci. 1981; 51: 199
  • Galbraith D. A., Watts D. C. The effect of ouabain on erythrocyte adenosine triphosphatase activity in relation to cell age in vivo and Duchenne muscular dystrophy. Biochem. Soc. Trans. 1980; 8: 718
  • Tortolero M., Fischer S., Piau J.-P., et al. Erythrocyte membrane protein kinase and adenylase cyclase in Duchenne muscular dystrophy. Biomedicine 1979; 30: 47
  • Somer H. Enzyme release from isolated erythrocytes and lymphocytes in Duchenne muscular dystrophy. J. Neurol. Sci. 1980; 48: 445
  • Davis M. H., Cappel R., Vester J. W., et al. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts. Muscle Nerve 1982; 5: 1
  • Ionasescu V., Ionasescu R., et al. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy. Ann. Neurol. 1981; 9: 394
  • Cavanagh N. P. C., Franklin G. I., Hughes B. P., et al. Creatine kinase isoenzymes in cultured human muscle cells. II. A study of carrier females for Duchenne muscular dystrophy by needle and open biopsy. Clin. Chim. Acta 1981; 115: 191
  • Franklin G. I., Cavanagh N. P. C., Hughes B. P., et al. Creatine kinase isoenzymes in cultured human muscle cells. I. Comparison of Duchenne muscular dystrophy with other myopathic and neurogenic diseases. Clin. Chim. Acta 1981; 115: 179
  • Thompson C. E. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy. New Engl. J. Med. 1978; 298: 1479
  • Ionasescu V., Zelleger H., Cancilla P. Fetal serum creatine-phosphokinase not a valid predictor of Duchenne muscular dystrophy. Lancet 1978; 1: 1251
  • Golbus M. S., Stephens J. D., Mahoney M. J., et al. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. New Engl. J. Med. 1979; 300: 860
  • Stempel L. E., Lott J. A. Diagnosis of fetal death in utero with amniotic fluid creatine kinase. Am. J. Obstet. Gynecol. 1980; 138: 1173
  • Kerenyi T., Sarkozi L. Diagnosis of fetal death in utero by elevated anmniotic fluid CPK levels. Obstet. Gynecol. 1974; 44: 215
  • Carter N. D., Heath R., Jeffery S., et al. Fetal plasma carbonic anhydrase III in Duchenne dystrophy. Lancet 1982; 1: 39
  • Sibert J. R., Harper P. S., Thompson R. J., et al. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases. Arch. Dis. Child. 1979; 54: 534
  • Hutton E. M., Thomson M. W. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Can. Med. Assoc. J. 1976; 115: 749
  • Perry T. B., Fraser F. C. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Neurology 1973; 23: 1316
  • Smith I., Thomson W. H. S. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: pyruvate kinase isoenzymes and creatine phosphokinase in serum and blood cells. Clin. Chim. Acta 1977; 78: 439
  • Moss D. W., Whitaker K. B., Parmar C., et al. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the “European” recommended method with NAC-EDTA activation. Clin. Chim. Acta 1981; 116: 209
  • Tippet P. A., Dennis N. R., Machin D., et al. Creatine kinase activity in the detection of carriers of Duchenne muscular dystrophy: comparison of two methods. Clin. Chim. Acta 1982; 121: 345
  • Percy M. E., Andrews D. F., Thompson W. M. Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing. Muscle Nerve 1982; 5: 58
  • Nicholson G. A., Pennington R. J. T., Gardner-Medwin D., et al. Carrier detection in Duchenne muscular dystrophy: assessment of the effect of age on detection-rate with serum creatine-kinase-activity. Lancet 1979; 1: 629
  • Moser H., Vogt J. Follow up study of serum creatinine kinase in carriers of Duchenne muscular dystrophy. Lancet 1974; 2: 661
  • Lange K., Zatz M. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy. Hum. Hered. 1979; 29: 154
  • Zatz M., Otto P. A. Effect of age on the detection rate in Duchenne muscular dystrophy. Neurol. Sci. 1980; 47: 407
  • Gale A. N., Murphy E. A. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. J. Chron. Dis. 1979; 32: 639
  • Smith I., Elton R. A., Thomson W. H. S. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women. Clin. Chim. Acta 1979; 98: 207
  • Nuttall F. Q., Jones B. Creatine kinase and glutamic oxaloacetic transaminase activity in serum: kinetics of change with exercise and effect of physical conditioning. J. Lab. Clin. Med. 1968; 71: 847
  • Berg A., Haralambie G. Changes in serum creatine kinase and hexose phosphate isomerase activity with exercise duration. Eur. J. Appl. Physiol. 1978; 39: 191
  • Wolfson S., Rose L. I., Brousser J. E., et al. Serum enzyme levels during exercise in patients with coronary heart disease: effects of training. Am. Heart J. 1972; 84: 478
  • Ledwich J. R. Changes in serum creatine phosphokinase during submaximal exercise testing. Can. Med. Assoc. J. 1973; 109: 273
  • McAllister R. G., Weidner L. Effect of treadmill exercise testing on serum enzymes and the resting electrocardiogram. Can. Med. Assoc., J. 1975; 112: 1310
  • Riley W. J., Pykes F. S., Roberts A. D., et al. The effect of long-distance running on some biochemical variables. Clin. Chim. Acta 1975; 65: 83
  • King S. W., Statland B. E., Savory J. The effect of a short burst of exercise on activity values of enzymes in sera of healthy young men. Clin. Chim. Acta 1976; 72: 211
  • Galteau M. M., Siest G., Poortmans J. Continuous in vivo measurement of creatine kinase variations in man during an exercise. Clin. Chim. Acta 1976; 66: 89
  • Chahine R. A., Kazantzis A., Luchi R. J., et al. Effect of routine treadmill testing on the serum enzymes. Cardiology 1976; 61: 162
  • Goode D. J., Meltzer H. Y. Effects of isometric exercise on serum creatine phosphokinase activity. Arch. Gen. Psychol. 1976; 33: 1207
  • Kaman R. L., Goheen B., Patton R., et al. The effects of near maximum exercise on serum enzymes: the exercise profile versus the cardiac profile. Clin. Chim. Acta 1977; 81: 145
  • LaPorta M. A., Linde H. W., Bruce D. L., et al. Elevation of creatine phosphokinase in young men after recreational exercise. JAMA 1978; 629: 2685
  • Olivier L. R., DeWaal A., Retief F. J., et al. Electrocardiographic and biochemical studies on marathon runners. S. Afr. Med. J. 1978; 53: 783
  • Rutledge J., Clayson P. E., Strandjord P. E. Effect of physical conditioning on serum creatine kinase after exercise. JAMA 1978; 240: 2633
  • Houston M., Green H., Thomson J., et al. The response of oxygen consumption, body temperature, blood substrates and serum enzymes to intermittent heavy work performed over 24 hours. Eur. J. Appl. Physiol. 1978; 39: 145
  • Kielblock A. J., Manjoo M., Booyens J., et al. Creatine phosphokinase and lactate dehydrogenase levels after ultra long-distance running. S. Afr. Med. J. 1979; 55: 1061
  • Haralambie G., Senser L. Metabolic changes in man during long-distance swimming. Eur. J. Appl. Physiol. 1980; 43: 115
  • Strauss R. H., Lott J. A., Bartells R., et al. Creatine kinase MB isoenzyme among competitive swimmers. New Engl. J. Med. 1982; 306: 1180
  • Apple F. S. Presence of creatine kinase MB isoenzyme during marathon training. New Engl. J. Med. 1981; 305: 764
  • Siegel A. J., Silverman L. M., Holman B. L. Elevated creatine kinase MB isoenzyme levels in marathon runners. JAMA 1981; 246: 2049
  • Demos M. A., Gitin E. L., Kagen L. J. Exercise myoglobinemia and acute exertional rhabdomyolysis. Arch. Intern. Med. 1975; 134: 669
  • Schiff H. B., MacSearraigh E. T. M., Kallmeyer J. C. Myoglobinuria, rhabdomyolysis and marathon running. Q. J. Med. 1978; 47: 463
  • Innes R. K. R., Stromme J. H. Rise in serum creatine phosphokinase associated with agents used in anaesthesia. Br. J. Anaesth. 1973; 45: 185
  • Phornphutkul K. S., Anuras S., Koff R. S., et al. Causes of increased plasma creatine kinase activity after surgery. Clin. Chem. 1974; 20: 340
  • Krafft J., Fink R., Rosalki S. Serum enzymes and isoenzymes after surgery. Ann. Clin. Biochem. 1977; 14: 294
  • Prellwitz W., Neumeier D. Creatine-kinase and CK-MB isoenzyme activity in serum of patients after surgical operations, polytrauma and other damage to skeletal muscle. Clin. Biochem. 1980; 13: 225
  • Ploetz J., Braun J. Failure of “self-taming” doses of succinylcholine to inhibit increases in postoperative serum creatine kinase activity in children. Anesthesiology 1982; 56: 207
  • Bendz R., Strom S. Diagnostic significance of serum CK-MB elevations following surgical damage to skeletal muscles. Scand. J. Thorac. Cardiovasc. Surg. 1981; 15: 199
  • Graeber G. M., Snyder R. J., Zajtchuk R., et al. A comparison of serum isoenzyme levels of creatine phosphokinase and lactic dehydrogenase in patients undergoing thoracic operations and patients admitted to a coronary care unit. Ann. Thorac. Surg. 1980; 30: 364
  • Dixon S. H., Limbird L. S., Roe C. R., et al. Recognition of post-operative acute myocardial infarction. Circulation 1973; 47(III)137
  • Oldham H. N., Roe C. R., Young W. G., et al. Intraoperative detection of myocardial damage during coronary artery surgery by plasma creatine phosphokinase isoenzyme analysis. Surgery 1974; 74: 917
  • Baur H. R., Steele B. W., Preimesberger K. F., et al. Serum myocardial creatine kinase (CK-MB) after coronary arterial bypass surgery. Am. J. Cardiol. 1979; 44: 679
  • Pyle R. B., Blomberg D. J., Burke M. D., et al. CPK-MB isoenzyme: use in diagnosis of acute myocardial infarction in early postoperative period. J. Thorac. Cardiovasc. Surg. 1976; 71: 884
  • Warren S. G., Wagner G. S., Bethea C. F., et al. Diagnostic and prognostic significance of electrocardiographic and CPK isoenzyme changes following coronary bypass surgery: correlation with findings at one year. Am. Heart J. 1977; 93: 189
  • Delva E., Maille J. G., Solymoss B. C., et al. Evaluation of myocardial damage during coronary artery grafting with serial determinations of serum CPK-MB isoenzyme. J. Thorac. Cardiovasc. Surg. 1978; 75: 467
  • Roe C. R., Wagner G. S., Young W. G., et al. Relation of creatine kinase isoenzyme MB to postoperative electrocardiographic diagnosis in patients undergoing coronary-artery bypass surgery. Clin. Chem. 1979; 25: 93
  • Sylven J. C. H., Bomfim V., Ivert T., et al. Myocardial and non-myocardial release of myoglobin and creatine-kinase MB following cardiac operations with hypothermic potassium cardioplegia. Cardiovasc. Res. 1982; 16: 151
  • Klapdor R., Harm K., Kugler G. Forschritte in der Differentialdiagnose des Herzinfarkts. Dtsch. Med. Wschr. 1977; 102: 1309
  • Anderson D. E., Damsgaard T. The effect on serum enzymes of intramuscular injections of digoxin, bumetanide, pentazocine and isotonic sodium chloride. Acta Med. Scand. 1976; 199: 317
  • Greenblat D. J., Duhme D. W., Koch-Weser J. Pain and CPK elevation after intramuscular digoxin. New Engl. J. Med. 1973; 288: 689
  • Klein M. S., Shell W. E., Sobel B. E. Serum creatine phosphokinase (CPK) isoenzymes after intramuscular injections, surgery, and myocardial infarction: experimental and clinical studies. Cardiovasc. Res. 1973; 7: 412
  • Meltzer H. Y., Mrozak S., Boyer M. Effect of intramuscular injections on serum creatine phosphokinase activity. Am. J. Med. Sci. 1970; 259: 42
  • Sidell F. R., Culver D. L., Kaminskis A. Serum creatine phosphokinase activity after intramuscular injection. The effect of dose, concentration and volume. JAMA 1974; 229: 1894
  • Vukovitch R. A. The effect of multiple intramuscular placebo injections on injection-site tolerance and serum creatine phosphokinase activity. Curr. Ther. Res. 1975; 18: 706
  • Matlof H. J., Buhl J., Wexler L., et al. Serum enzymes and electrocardiograms after coronary arteriography. New Engl. J. Med. 1973; 288: 142
  • Lindsey D., Navin T. R., Finley P. R. Transient elevations of serum activity of MB isoenzymes of creatine phosphokinase in drivers involved in automobile accidents. Chest 1978; 74: 15
  • Chemnitz G., Schmidt E., Schmidt F. W., et al. Das Creatinkinase Isoenzym MB im Serum bei extrakardialen Erkrankungen. Vern. Dtsch. Ges. Inn. Med. 1978; 84: 1587
  • Shell W. E., Kligerman M., Rorke M. P., et al. Sensitivity and specificity of MB creatine kinase activity determined with column chromatography. Am. J. Cardiol. 1979; 44: 67
  • Hackl J. M., Haid B., Puschendorf B., et al. Differentialdiagnose von Skelettmuskel- und Herzmuskeltrauma bei polytraumatischen Verletzungen durch Bestimmung der herzspezifischen Kreatinphos-phokinase (CK-MB). Wien Klin. Wschr. 1978; 90: 595
  • Biswas C. K., Milligan D. A., Agle S. D., et al. Acute renal failure and myopathy after treatment with amino caproic acid. Br. Med. J. 1980; 281: 115
  • Lane R. J. M., Mastaglia F. L. Drug-induced myopathies in man. Lancet 1978; 2: 562
  • Schneider J. Clinical importance of clofibrate induced increase of CK catalytic activity in serum. J. Clin. Chem. Clin. Biochem. 1981; 19: 539
  • Gerard J.-M., Leboutte G. H. C. Crampes musculaires et Elevation des Creatines Kinases induites par le Danazol. Rev. Med. Brux. 1981; 2: 995
  • Spaulding W. B. Myalgia and elevated creatine phosphokinase with Danazol in hereditary angioedema. Ann. Intern. Med. 1979; 90: 854
  • Cohen L., Morgan J. DES effects on serum enzyme and isoenzymes in muscular dystrophy. Arch. Neurol. 1976; 33: 480
  • Cohen L., Morgan J., Bozyk M. E. Effects of the simultaneous administration of DES and prednisolone on serum enzymes in Duchenne's muscular dystrophy. J. Med. 1977; 8: 723
  • Lui W. Y. Phenothiazine-induced dystonia associated with an increase in serum creatine phosphokinase. Arch. Dis. Child. 1979; 54: 150
  • Teicher A., Rosenthal T., Kissen E., et al. Labetalol-induced toxic myopathy. Br. Med. J. (Clin. Res.) 1981; 282: 1824
  • Yagiela J. A., Beneit P. W., Buoncristian R. D., et al. Comparison of myotoxic effect of lidocaine with epinephrine in rats and humans. Anaesth. An. 1981; 60: 471
  • Imatak K., Seki A., Takahashi N., et al. Elevation of serum creatine kinase during pindolol therapy. Tohoku J. Exp. Med. 1981; 133: 363
  • Weiss M., Hassin D., Eisenstein Z., Bank H. Elevated skeletal muscle enzymes during quinidine therapy. New Engl. J. Med. 1979; 300: 1218
  • Charak D. S., Dhar C. L. Suxamethonium-induced changes in serum creatine phosphokinase. Br. J. Anaesth. 1981; 53: 955
  • Lewandowski K. B. Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations. Br. J. Anaesth. 1981; 53: 981
  • Sabiniewicz M., Szajewski J. M. Creatine phosphokinase and barbiturate overdose. Lancet 1979; 152
  • Wright N., Clarkson A. R., Brown S. S., et al. Effect of poisoning on serum enzyme activities, coagulation and fibrinolysis. Br. Med. J. 1971; 3: 347
  • Lafair J. S., Myerson R. M. Alcoholic myopathy. Arch. Intern. Med. 1968; 122: 417
  • Nygren A. Serum creatine phosphokinase activity in chronic alcoholism in connection with acute alcohol intoxication. Acta Med. Scand. 1966; 179: 623
  • DiSilvio T. V. Alcoholic myopathy and changes of serum enzyme activity. Clin. Chem. 1978; 24: 1653
  • Harm K., Burchard J. M., Bartels E., et al. Differential diagnostic importance of the creatine kinase isoenzyme pattern in delirium tremens. Klin. Wschr. 1979; 57: 943
  • Henderson L. W., Metz M., Wilkinson J. H. Serum enzyme elevation in glutethimide intoxication. Br. Med. J. 1970; 3: 751
  • Lithell H., Bobers J., Hellsin K., et al. Increase of lipoprotein lipase activity in human skeletal muscle during clofibrate administration. Eur. J. Clin. Invest. 1978; 8: 67
  • Abourizk N., Khalil B. A., Bahuth N., et al. Clofibrate-induced muscular syndrome. Report of a case with clinical, electromyographic and pathologic observations. J. Neurol. Sci. 1979; 42: 1
  • Cans W. R., Hoffman J., Huebschmann K., et al. Myopathy induced by clofibrate treatment in normolipemic patients. Acta Paediatr. Acad. Sci. Hung. 1979; 20: 109
  • Schneider J., Muehlfellner G., Kaffarnik H. Creatine kinase in hyperlipoproteinemic patients treated with clofibrate. Artery 1980; 8: 164
  • Sheffer A. C., Fearson D. T., Austen K. F. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. J. Allergy Clin. Immunol. 1981; 68: 181
  • Fraser A. D. Chemotherapy as a cause of low serum creatine kinase activity. Clin. Chem. 1980; 26: 1629
  • Siegel A. J., Dawson D. M. Peripheral source of MB band of CK in alcoholic rhabdomylosis. Non-specificity of MB isoenzyme for myocardial injury in undiluted serum samples. JAMA 1980; 244: 580
  • Spector R., Choudhury A., Cancilla P., et al. Alcoholic myopathy. Diagnosis by alcohol challenge. JAMA 1979; 242: 1648
  • Langohr H. D., Schumm F., Luithle H. J., et al. Vergleichende biochemische und elektrophysiol-ogische Untersuchungen in der Skeletmuskulatur bei Alkoholismus. Arch. Psychiatr. Nervenkr. 1977; 223: 249
  • Marian C., Meola G., Meroni P. L., et al. Pentazocine-induced neuromuscular syndromes: clinical, immunological and histopathological studies in two cases. Acta Neuropathol. Suppl. (Bed.) 1981; 7: 246
  • Dolich B. H., Aiache A. E. Drug-induced coma: a cause of crush syndrome and ischemic contracture. J. Trauma 1973; 13: 223
  • Galen R. S. In the aftermath of drug-induced coma, suspect crush syndrome. Diag. Med. Nov.-Dec. 9, 1979
  • Sueblinvong V., Wilson J. F. Myocardial damage due to imipramine intoxication. Pediatr. Pharmacol. Ther. 1969; 74: 475
  • Demeyere R. Malignant hyperthemia. Acta Anaesth. Belg. 1978; 29: 101
  • Britt B. A. Etiology and pathophysiology of malignant hyperthermia. Fed. Proc. 1979; 38: 44
  • Gronert G. A. Malignant hyperthermia. Anesthesiology 1980; 53: 395
  • Britt B. A., Endrenyi L., Peters P. L. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations. Can. Anaesth. Soc. J. 1976; 23: 263
  • Pandit S. K., Kothary S. P., Cohen P. J. Orally administered dantrolene for prophylaxis of malignant hyperthermia. Anesthesiology 1979; 50: 156
  • Bronstein S. L., Ryan D. E., Solomons C. C., et al. Dantrolene sodium in the management of patients at risk for malignant hyperthermia. J. Oral Surg. 1979; 37: 719
  • Dodd M. J., Phattiyakl P., Silpasuvan S. Suspected malignant hyperthermia in a strabismus patient. A case report. Arch. Ophthalmol. 1981; 99: 1247
  • Caccia M. R., Cerri C., Gravame V., et al. Myopathy with paroxysmal myoglobinuria and focal muscle necrosis following enfluorane anesthesia. J. Neurol. Sci. 1978; 39: 61
  • Fitzgibbon D. C. Malignant hyperthermia following preoperative oral administration of dantrolene. Anesthesiology 1981; 54: 73
  • Henderson W. V., Wooten G. F. Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockage?. Neurology 1981; 31: 132
  • Torn M., Matsuda O., Makiguchi K., et al. Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs. J. Nerv. Ment. Dis. 1981; 169: 324
  • Malas K. L., Van Kammen D. P. Marked elevated CK levels after neuroleptic withdrawal. Am. J. Psychiatry 1982; 139: 231
  • Pedersen L. M., Nygaard E., Nielsen D. S., et al. Solvent-induced occupational myopathy. J. Occup. Med. 1980; 22: 603
  • Morse D. L., Kominsky J. R., Wisseman C. L., et al. Occupational exposure to hexachlorocylo-pentadiene. How safe is sewage?. JAMA 1979; 241: 2177
  • Hoffman T. A., Ruiz C. J., Counts G. W., et al. Waterbome typhoid fever in Dade county, Florida. Am. J. Med. 1975; 59: 481
  • David C. B., Tolaymat A. Typhoid fever: unusual presentation. J. Pediatr. 1978; 95: 533
  • Lott J. A., Speicher C. E., Ayers L. W. Typhoid fever toxemia with associated destruction of skeletal muscle. Clin. Chem. 1980; 26: 1361
  • Kiyasu J. Detection of septicemia by the shot-gun method for assaying creatine kinase isoenzyme MB in serum. Clin. Chem. 1978; 24: 2064
  • Sexton D. J., Banks P. M., Weig S., et al. Late appearance of skin rash and abnormal serum enzymes in Rocky Mountain spotted fever: a case report. J. Pediatr. 1975; 87: 580
  • Johnson W. D., Jr., Silva C., Rocha H. Serum creatine phosphokinase in leptospirosis. JAMA 1975; 233: 981
  • Farkas P. S., Knapp A. B., Lieberman H., et al. Markedly elevated creatinine phosphokinase, cotton wool spots, and pericarditis in a patient with leptospirosis. Gastroenterology 1981; 80: 587
  • Friman G. Serum creatine phosphokinase in epidemic influenza. Scand. J. Infect. Dis. 1976; 8: 13
  • Chandar K., Mair H. J., Mair N. S. Case of toxoplasma polymyositis. Br. Med. J. 1968; 1: 158
  • Dobrin R. S. Reye's syndrome—1980. Resid Staff Physics March, 1980; 79
  • Atkins J. N., Haponik E. F. Reye's syndrome in the adult patient. Am. J. Med. 1979; 67: 672
  • Rock R. C., Dreskin R., Kickler T., et al. Creatine kinase isoenzymes in serum of patients with Reye's syndrome. Clin. Chim. Acta 1975; 62: 159
  • Roe C. R., Schonberger L., Gehlbach S. H., et al. Enzymatic alterations in Reye's syndrome: prognostic implications. Pediatrics 1975; 55: 119
  • Forman D. T., Kieffer H., Grayson S. H. Serum creatine kinase inhibition in Reye's syndrome. Clin. Chem. 1977; 23: 1364
  • Edwards R. H. T., Isenberg D. A., Wiles C. M., et al. The investigation of inflammatory myopathy. J. R. Coll. Phys. 1981; 15: 19
  • Durston J. H. J. Disorders of skeletal muscle. Br. J. Hosp. Med. 1974; 11: 590
  • Robbins S. L. Pathologic Basis of Disease. W. B. Saunders, Philadelphia 1974; 239
  • Pearce J. M. S., Pennington R. J., Walton J. N. Serum enzyme studies in muscle disease. II. Serum creatine kinase activity in muscular dystrophy and in other myopathic and neuropathic disorders. J. Neurol. Neurosurg. Psychiatry 1964; 27: 96
  • Richterich R., Rosin S., Aebi U., et al. Progressive muscular dystrophy, V. The identification of the carrier state in the Duchenne type by serum creatine kinase determination. Am. J. Hum. Genet. 1963; 15: 133
  • Vladutiu A. O., Venuto R. C. Creatine kinase MB and lactate dehydrogenase-5 isoenzymes in rhabdomyolysis. Clin. Chem. 1977; 23: 1366
  • Brownlow K., Elevitch F. R. Serum creatine phosphokinase isoenzyme (CPK 2) in myositis. JAMA 1974; 230: 1141
  • Tsung S. H., Huang T. Y., Han D., et al. Total creatine kinase and isoenzyme MB activity in serum and skeletal muscle of a patient with dermatomyositis. Clin. Chem. 1980; 26: 1912
  • Tsung S. H., Huang T. Y., Lin J. I. CK-MB isoenzyme in patients with polymyositis. Am. J. Med. Sci. 1982; 283: 174
  • Larca L. J., Coppola J. T., Honig S. Creatine kinase MB isoenzyme in dermatomyositis: a noncardiac source. Ann. Intern. Med. 1981; 94: 341
  • Morton B. D., Statland B. E. Serum enzyme alterations in polymyositis: possible pitfalls in diagnosis. Am. J. Clin. Pathol. 1980; 73: 556
  • Cros D., Pearson C., Verity M. A. Polymyositis-dermatomyositis. Am. J. Pathol. 1980; 101: 159
  • Griffiths P. D. Serum enzymes in diseases of the thyroid gland. J. Clin. Pathol. 1965; 18: 660
  • Doran G. R., Wilkinson J. H. The origin of the elevated activities of creatine kinase and other enzymes in the sera of patients with myxoedema. Clin. Chim. Acta 1975; 62: 203
  • Gaeda J. T. Serum enzyme alterations in hypothyroidism before and after treatment. J. Am. Geriatr. Soc. 1977; 25: 199
  • Feix C., Skachova J., Kunova V. Creatine phosphokinase in thyroid disease. Rev. Czech. Med. 1977; 23: 133
  • Goldman J., Matz R., Mortimer R., et al. High elevations of creatine phosphokinase in hypothyroidism. An isoenzyme analysis. JAMA 1977; 238: 325
  • Jenkins D. J. An investigation into creatine kinase and other plasma enzymes in thyroid disorders. Clin. Chim. Acta 1978; 85: 197
  • Emser W., Schimrigk K. Myxedema myopathy: a case report. Eur. J. Neurol. 1977; 16: 286
  • Goto I. Serum creatine phosphokinase isoenzymes in hypothyroidism, convulsion, myocardial infarction and other diseases. Clin. Chim. Acta 1974; 52: 27
  • Fleisher G. A., McConahey W. M., Pankow M. Serum creatine kinase, lactic dehydrogenase, and glutamic-oxalacetic transaminase in thyroid disease and pregnancy. Mayo Clin. Proc. 1965; 40: 300
  • Smith D. P. The relationship between serum creatine kinase and thyroid hormones: in vivo and in vitro studies. Clin. Chim. Acta 1976; 68: 333
  • Crawhall J. C., Tolis G., Roy D. Elevation of serum creatine kinase in severe hypokalemic hyperaldosteronism. Clin. Biochem. 1976; 9: 237
  • Hoag G. N., Franks G. R., DeCoteau W. E. Creatine kinase isoenzymes in serum of patients with cancer of various organs. Clin. Chem. 1978; 24: 1654
  • Bruns D. E., Morgan W. S., Davis J. E., et al. Low apparent creatine kinase activity and prolonged lag phases in serum of patients with metastatic disease: elimination by treatment of sera with sulfhydryl agents. Clin. Chem. 1976; 22: 1889
  • Yu H., Takagi Y., Senju O., et al. Creatine kinase isoenzyme of high relative molecular mass in serum of a cancer patient. Clin. Chem. 1978; 24: 2054
  • Calvin A. Raised serum creatine phosphokinase activity in ankylosing spondylitis. Ann. Rheum. Dis. 1975; 34: 244
  • Halvorson H. C., Bias H. I., Kaldahl P. E., et al. Elevated creatine phosphokinase in patients with urethral calculi. Cause for unwarranted concern of coronary occlusion. Urology 1974; 4: 254
  • Konttinen A., Somer H., Auvinen S. Serum enzymes and isoenzymes, extrapulmonary sources in acute pulmonary embolism. Arch. Int. Med. 1974; 133: 243
  • Lemberg A., Werber D. H., Gilardoni A., et al. Presence of serum creatine kinase isoenzymes in liver failure with cerebral involvement. Clin. Chim. Acta 1977; 80: 385
  • Barlogie B., Corry P. M., Yip E., et al. Total body hyperthermia with and without chemotherapy for advanced human neoplasms. Cancer Res. 1979; 39: 1481
  • Carlson C. J., Emilson B., Rapaport E. Creatine phosphokinase MB isoenzymes in hypothermia: case reports and experimental studies. Am. Heart J. 1973; 95: 352
  • Heinz J. A., O'Donnell N. J., Lott J. A. Apparent mitochondrial creatine kinase in the serum of a patient with metastatic cancer to the liver. Clin. Chem. 1980; 26: 1908
  • Kwong T. C., Arvan D. A. How many creatine kinase isoenzymes are there and what is their clinical significance?. Clin. Chim. Acta 1981; 115: 3
  • Tsung S. W. Creatine kinase isoenzyme patterns in human tissue obtained at surgery. Clin. Chem. 1976; 22: 173
  • Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended methods for the determination of creatine kinase in blood modified by the inclusion of EDTA. Scand. J. Clin. Lab. Invest. 1979; 39: 1
  • Bodensteiner J. B., Zellweger H. Creatine phosphokinase in normal neonates and young infants. J. Lab. Clin. Med. 1971; 11: 853
  • Rudolph N., Gross R. T. Creatine phosphokinase activity in serum of newborn infants as an indicator of fetal trauma during birth. Pediatrics 1966; 38: 1039
  • Menzel K., Braun W. F. Verteilungsmuster der Serum-LDH und -CPK bei gesunden Neugeborenen. Kinderaerztl. Prax 1974; 42: 128
  • Dubowitz V. Screening for Duchenne muscular dystrophy. Arch. Dis. Child. 1976; 51: 249
  • Gilboa N., Swanson J. R. Serum creatine phosphokinase in normal newborns. Arch. Dis. Child. 1976; 51: 283
  • Jouppila R., Jouppila P., Koivisto M., et al. Maternal, fetal, and neonatal blood creatine phosphokinase activities and creatine phosphokinase isoenzymes after labor with and without epidural analgesia and after Caesarean section. Acta Anaesth. Scand. 1978; 22: 491
  • Drummond L. M. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch. Dis. Child. 1979; 54: 362
  • Cao A., Trabalza N., DeVirgilis S., et al. Serum creatine kinase activity and serum CK isoenzymes in newborn infants. Biol. Neonate 1971; 17: 126
  • Hess J. W., MacDonald R. P., Natho G. J. W., et al. Serum creatine phosphokinase: Evaluation of a commercial spectrophotometric method. Clin. Chem. 1967; 13: 994
  • Wiesman M., Columbo J. P., Adam A., et al. Determination of cysteine activated creatine kinase in serum. Enzymol. Biol. Clin. 1966; 7: 266
  • Verri B., Macagno F., Corazza G. Creatine phosphokinase (CPK) in children of different ages. Minerva Pediat. 1966; 18: 2256
  • Cherian A. G., Hill J. G. Age dependence of serum enzymatic activities (alkaline phosphatase, aspartate aminotransferase and creatine kinase) in healthy children and adolescents. Am. J. Clin. Pathol. 1978; 70: 783
  • Worthy E., Whitehead P., Goldberg D. M. Advantages and limitations of a simplified colorimetric assay for ATP: creatine phosphotransferase activity of human serum. Enzymol. Biol. Clin. 1970; 11: 193
  • Griffiths P. D. Serum levels of ATP: reatine phosphotransferase (creatine kinase): the normal range and effect of muscular activity. Clin. Chim. Acta 1966; 13: 413
  • Garcia W. Elevated creatine phosphokinase levels associated with large muscle mass. JAMA 1974; 228: 1395
  • Thomson W. H. S. Determination and statistical analysis of the normal ranges for five serum enzymes. Clin. Chim. Acta 1968; 21: 469
  • Szasz G., Busch E. W., Farohs H. B. Serum Kreatinkinase. Dtsch. Med. Wschr. 1970; 95: 829
  • Feraudi M., Harm K., Schmidt H. Statische Untersuchung der Frage der Normalwerte und der physiologischen Variabilitaet der Serum-Kreatin-Phosphokinase. Enzymol. Biol. Clin. 1968; 9: 338
  • Meltzer H. Y. Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity, and age. Clin. Chim. Acta 1971; 33: 165
  • Lott J. A., Wenger W. C., Massion C. G., et al. Interlaboratory survey of enzyme analyses. IV. Am. J. Clin. Pathol. 1982; 78: 626
  • Perry T. B., Fraser F. C. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Neurology 1973; 23: 1316
  • Bundey S., Crawley J. M., Edwards J. H., et al. Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women. J. Med. Genet. 1979; 16: 117
  • Smith I., Elton R. A., Thomson W. H. S. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women. Clin. Chim. Acta 1979; 98: 207
  • Chemnitz G., Nevermann K., Schmidt E., et al. Creative kinase and creatine kinase isoenzymes during pregnancy and labor and in the cord blood. Clin. Biochem. 1980; 13: 277
  • McNeely M. D. D., Berris B., Papsin F. R., et al. Creatine kinase and its isoenzymes in the serum of women during pregnancy and the peripartum period. Clin. Chim Acta 1977; 23: 1878
  • Amador E., Ansar A. Analytical aspects of clinical enzymology. aClinical Chemistry, D. T. Forman, R. W. Mattoon. American Chemical Society, Washington, DC 1976; 36
  • Lott J. A., Turner K. Lactate dehydrogenase in serum. Selected Methods for the Small Clinical Chemistry Laboratory, W. R. Faulkner, S. Meites. W. B. Saunders, Philadelphia 1982; 271
  • Wroblewski F., Gregory K. F. Lactic dehydrogenase isoenzymes and their distribution in normal tissue and plasma and in disease states. Ann. N. Y. Acad. Sci. 1961; 94: 912
  • Meites S. Pediatric Clinical Chemistry. American Association for Clinical Chemistry. 1982; 300
  • Expert Panel on Enzymes. Clin. Chim. Acta 1980; 105: 147F
  • Anon. Provisional recommendation on I. F. C. C. methods for the measurement of catalytic concentrations of enzymes. Clin. Chim. Acta 1976; 70: F19
  • Wroblewski F. Clinical significants of alterations in transaminase activities of serum and other body fluids. Adv. Clin. Chem. 1958; 1: 313
  • Caraway W. T. Chemical and diagnostic specificity of laboratory tests. Effect of hemolysis, lipemia, anticoagulants, medications, contaminants, and other variables. Am. J. Clin. Pathol. 1962; 37: 445
  • Meites S. Pediatric Clinical Chemistry. American Association for Clinical Chemistry. 1982; 59, 117
  • Meites S. Pediatric Clinical Chemistry. American Association for Clinical Chemistry. 1982; 63
  • Cederblad C., Bylund A. C., Holm J., et al. Carnitine concentration in relationship to enzyme activities and substrate utilization. Scand. J. Clin. Invest. 1976; 36: 547
  • Haralambie G. Fumarase activity in skeletal muscle of man. Biomedicine 1977; 27: 255
  • Adolph L., Lorenz R. Enzyme Diagnosis in Diseases of the Heart, Liver, and Pancreas. S. Karger AG, Switzerland 1982; 14
  • Lott J. A., Heinz J. W. Creatine kinase in serum. Selected Methods for the Small Clinical Chemistry Laboratory, W. R. Faulkner, S. Meites. W. B. Saunders, Philadelphia 1982; 185
  • Lott J. A. Creatine kinase isoenzymes in serum. Selected Methods for the Small Clinical Chemistry Laboratory, W. R. Faulkner, S. Meites. W. B. Saunders, Philadelphia 1982; 191

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.